https://charts.traderzeitung.de/phases/US65443P1021
string(1394) "{"isin":"US65443P1021","name":"908 Devices Inc","stock_id_xnas":16776207,"stock_id_xnys":null,"generated_at":"2026-09-24 01:31:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":10.88,"close_at":"2026-09-21 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":11.19,"close_at":"2026-09-22 21:59:00","complete":true,"perf_pct":2.8493},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":10.95,"close_at":"2026-09-23 21:59:00","complete":true,"perf_pct":-2.1448},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"
908 Devices

908 Devices Aktie News & Nachrichten

[WKN: A2QK1S | Symbol: MASS]
Realtimekurs
   
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über 908 Devices gefunden werden.

MT Newswires 17.09.2026 23:32 Uhr

908 Devices: Insider verkaufte Aktien im Wert von 280.070 US-Dollar laut einer aktuellen SEC-Meldung

05:31 PM EDT, 17.09.2026 (MT Newswires) -- John Kenneweg, Senior Vice President, Sales & Product Marketing, verkaufte am 15. September 2026 27.656

MT Newswires 10.09.2026 13:17 Uhr

Canaccord Genuity nimmt 908 Devices mit einer Buy-Bewertung und einem Kursziel von 13,50 USD neu in die Analyse auf

07:16 AM EDT, 09/10/2026 (MT Newswires) -- 908 Devices (MASS) hat laut von FactSet befragten Analysten ein durchschnittliches Rating von Buy und ein m

MT Newswires 29.07.2026 13:41 Uhr

Roth Capital nimmt 908 Devices mit Buy und einem Kursziel von 11 USD neu auf

07:34 AM EDT, 29.07.2026 (MT Newswires) -- 908 Devices (MASS) hat laut von FactSet befragten Analysten ein durchschnittliches Rating von Buy und ein m